RHIZEN PHARMACEUTICALS S A has a total of 109 patent applications. It increased the IP activity by 500.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), Republic of Korea and Hungary. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are CALASIA PHARMACEUTICALS INC, MOUNT COOK BIOSCIENCES INC and PAINCEPTOR PHARMA CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 22 | |
#2 | Republic of Korea | 22 | |
#3 | Hungary | 9 | |
#4 | Serbia | 8 | |
#5 | Brazil | 7 | |
#6 | Hong Kong | 7 | |
#7 | Israel | 6 | |
#8 | Canada | 4 | |
#9 | Colombia | 4 | |
#10 | EAPO (Eurasian Patent Organization) | 4 | |
#11 | Chile | 3 | |
#12 | China | 3 | |
#13 | Australia | 2 | |
#14 | Singapore | 2 | |
#15 | South Africa | 2 | |
#16 | African Regional Industrial Property Organization | 1 | |
#17 | Argentina | 1 | |
#18 | Mexico | 1 | |
#19 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Biotechnology | |
#5 | Foods and drinks | |
#6 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Viswanadha Srikant | 74 |
#2 | Muthuppalaniappan Meyyappan | 46 |
#3 | Vakkalanka Swaroop Kumar V S | 41 |
#4 | Babu Govindarajulu | 40 |
#5 | Vakkalanka Swaroop Kumar Venkata Satya | 33 |
#6 | Nagarathnam Dhanapalan | 24 |
#7 | Merikapudi Gayatri Swaroop | 19 |
#8 | Bhavar Prashant Kashinath | 17 |
#9 | Muthuppalaniappan Peyyappan | 16 |
#10 | Bhavar Prashant K | 10 |
Publication | Filing date | Title |
---|---|---|
HK1253000A1 | Pyrazole derivatives as modulators of calcium release-activated calcium channel | |
KR20160027049A | Pi3k protein kinase inhibitors, particularly delta and/or gamma inhibitors | |
IL229235D0 | 4h-chromen-4-one derivatives as modulators of protein kinases | |
HUE045210T2 | Selective pi3k delta inhibitors | |
HUE051029T2 | Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals | |
KR20190097318A | Novel benzopyran kinase modulators |